Canadian Association for Porphyria

Porphyria Treatment

Panhematin Treatment for Hepatic Porphyria (AIP, VP, HCP)

Treatment Guidelines for Canadians with Acute Hepatic Porphyria

There are no specific Canadian Treatment Guidelines for Canadians with Acute Hepatic Porphyria. The following best practice guideline and recommendations are included below. The Porphyrias Consortium in the United States has Treatment and Prognosis for the Acute Porphyrias information for Panhematin.

Best practice guidelines on: Clinical management of acute attacks of porphyria and their complications 

Recommendations for the Diagnosis and Treatment of the Acute Porphyria

Treatment and Prognosis for the Acute Porphyrias

Source: Product Information - Orphan Europe

Last Updated: 12/January/2017 

Medical Disclaimer

Care has been taken to ensure that the information on this website is accurate at the time of publication. This information is, however, intended for general guidance only and is not meant to substitute consultation from a recognized health professional. The Canadian Association for Porphyria/Association Canadienne de Porphyrie disclaims for itself and for the author of this information, all responsibility for any mis-statements or for consequences of actions taken by any person while acting on information contained herein. Physicians and patients must make their own decisions about therapy according to the individual circumstances of each case.

Powered by Wild Apricot Membership Software